THERAPEUTIC DRUG MONITORING
Therapeutic drug monitoring is used to optimise drug regimens for the individual patient by increasing efficacy and avoiding drug-related toxicity. Prospective surveys suggest 20% patients in clinic have sub-therapeutic plasma concentrations of PIs and NNRTIs, while the inter-individual variability in plasma concentrations is immense (≥100-fold difference) despite standard dosing.
To review Liverpool HIV Pharmacology Group drug interactions web-site: LHPG
|
 |
Therapeutic drug monitoring is sponsored by the following pharmaceutical company for the drug / patient category listed. Please contact your MSD representative for full details. The company will be invoiced directly for the cost of the analysis.
| Merck Sharpe & Dohme: |
Indinavir in cases of suspected toxicity |
|
|
|
